 | Up a level |
Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
de Botton, S; Sanz, MA; Chevret, S; Dombret, H; Martin, G; Thomas, X; Mediavilla, JD; Recher, C; Ades, L; Quesnel, B; Brault, P; Fey, M; Wandt, H; Machover, D; Guerci, A; Maloisel, F; Stoppa, AM; Rayon, C; Ribera, JM; Chomienne, C; ... (2006). Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia, 20(1), pp. 35-41. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404006
